Myomo, Inc.
Myomo, Inc. (NYSE American: MYO) is a wearable medical robotics company that develops and markets the MyoPro line of custom-fabricated, myoelectric upper-limb orthoses. The devices use non-invasive sensors to detect a user’s muscle signals and powered assistance to support movement of a weak or partially paralyzed arm… From the company’s description.
Over the twelve months to Jun 30, 2026, Myomo, Inc. reported revenue of $43.26M, up 6.1% from a year earlier, and a net loss of $14.51M. Its operating margin was −27.1%, and operations used $7.11M in cash. In fiscal 2025, it reported revenue of $40.93M, up 25.7% from fiscal 2024, and a net loss of $15.57M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Myomo, Inc. does
In the company’s own words
Myomo, Inc. (NYSE American: MYO) is a wearable medical robotics company that develops and markets the MyoPro line of custom-fabricated, myoelectric upper-limb orthoses. The devices use non-invasive sensors to detect a user’s muscle signals and powered assistance to support movement of a weak or partially paralyzed arm and hand, helping users perform daily activities such as reaching, lifting and grasping. They are intended for adults and adolescents with neuromuscular conditions, including stroke, brachial plexus injury, spinal cord injury and traumatic brain injury. Myomo evaluates, measures and fits patients through its clinical staff, bills insurers directly for some devices, and also sells through orthotics and prosthetics providers, the Veterans Administration and international accounts. The company operates as one business segment. Its products include the MyoPro 2 and MyoPro2x; MyoPal is a planned pediatric device, while MyoGames supports patient training. Myomo reported 35 issued patents and 14 pending applications in the United States and international markets.
Company details
- Sector
- Health Care
- Industry (SIC)
- Medical Instruments
- Headquarters
- BOSTON, MA
- Fiscal year end
- December
- CIK
- 1369290
- SIC
- 3842
Financial performance, year by year
Fiscal 2017–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Myomo, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Myomo, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Myomo, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Myomo, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Myomo, Inc.'s last four quarterly filings that the numbers alone won't show?”